

Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials.
Highlights
The global Polymerase Chain Reaction (PCR) Test market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Polymerase Chain Reaction (PCR) Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Polymerase Chain Reaction (PCR) Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Polymerase Chain Reaction (PCR) Test in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Polymerase Chain Reaction (PCR) Test include Abbott Laboratories, Agilent Technologies Inc., Abbott, Asuragen, Inc., Danaher, Biocartis Group Nv, µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ, Bio-Rad Laboratories, Inc. and Genmark Diagnostics, Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymerase Chain Reaction (PCR) Test.
The Polymerase Chain Reaction (PCR) Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Polymerase Chain Reaction (PCR) Test market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymerase Chain Reaction (PCR) Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
Agilent Technologies Inc.
Abbott
Asuragen, Inc.
Danaher
Biocartis Group Nv
µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ
Bio-Rad Laboratories, Inc.
Genmark Diagnostics, Inc.
Hologic, Inc.
Luminex Corporation
Meridian Bioscience, Inc.
Qiagen N.V.
Quantumdx Group
Quidel, Inc.
Roche
Segment by Type
Instruments
Reagents & Consumables
Software & Services
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polymerase Chain Reaction (PCR) Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Polymerase Chain Reaction (PCR) Test Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Instruments
1.2.3 Reagents & Consumables
1.2.4 Software & Services
1.3 Market by Application
1.3.1 Global Polymerase Chain Reaction (PCR) Test Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Polymerase Chain Reaction (PCR) Test Market Perspective (2018-2029)
2.2 Polymerase Chain Reaction (PCR) Test Growth Trends by Region
2.2.1 Global Polymerase Chain Reaction (PCR) Test Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Polymerase Chain Reaction (PCR) Test Historic Market Size by Region (2018-2023)
2.2.3 Polymerase Chain Reaction (PCR) Test Forecasted Market Size by Region (2024-2029)
2.3 Polymerase Chain Reaction (PCR) Test Market Dynamics
2.3.1 Polymerase Chain Reaction (PCR) Test Industry Trends
2.3.2 Polymerase Chain Reaction (PCR) Test Market Drivers
2.3.3 Polymerase Chain Reaction (PCR) Test Market Challenges
2.3.4 Polymerase Chain Reaction (PCR) Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Polymerase Chain Reaction (PCR) Test Players by Revenue
3.1.1 Global Top Polymerase Chain Reaction (PCR) Test Players by Revenue (2018-2023)
3.1.2 Global Polymerase Chain Reaction (PCR) Test Revenue Market Share by Players (2018-2023)
3.2 Global Polymerase Chain Reaction (PCR) Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Polymerase Chain Reaction (PCR) Test Revenue
3.4 Global Polymerase Chain Reaction (PCR) Test Market Concentration Ratio
3.4.1 Global Polymerase Chain Reaction (PCR) Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polymerase Chain Reaction (PCR) Test Revenue in 2022
3.5 Polymerase Chain Reaction (PCR) Test Key Players Head office and Area Served
3.6 Key Players Polymerase Chain Reaction (PCR) Test Product Solution and Service
3.7 Date of Enter into Polymerase Chain Reaction (PCR) Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Polymerase Chain Reaction (PCR) Test Breakdown Data by Type
4.1 Global Polymerase Chain Reaction (PCR) Test Historic Market Size by Type (2018-2023)
4.2 Global Polymerase Chain Reaction (PCR) Test Forecasted Market Size by Type (2024-2029)
5 Polymerase Chain Reaction (PCR) Test Breakdown Data by Application
5.1 Global Polymerase Chain Reaction (PCR) Test Historic Market Size by Application (2018-2023)
5.2 Global Polymerase Chain Reaction (PCR) Test Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Polymerase Chain Reaction (PCR) Test Market Size (2018-2029)
6.2 North America Polymerase Chain Reaction (PCR) Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Polymerase Chain Reaction (PCR) Test Market Size by Country (2018-2023)
6.4 North America Polymerase Chain Reaction (PCR) Test Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Polymerase Chain Reaction (PCR) Test Market Size (2018-2029)
7.2 Europe Polymerase Chain Reaction (PCR) Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Polymerase Chain Reaction (PCR) Test Market Size by Country (2018-2023)
7.4 Europe Polymerase Chain Reaction (PCR) Test Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Polymerase Chain Reaction (PCR) Test Market Size (2018-2029)
8.2 Asia-Pacific Polymerase Chain Reaction (PCR) Test Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Polymerase Chain Reaction (PCR) Test Market Size by Region (2018-2023)
8.4 Asia-Pacific Polymerase Chain Reaction (PCR) Test Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Polymerase Chain Reaction (PCR) Test Market Size (2018-2029)
9.2 Latin America Polymerase Chain Reaction (PCR) Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Polymerase Chain Reaction (PCR) Test Market Size by Country (2018-2023)
9.4 Latin America Polymerase Chain Reaction (PCR) Test Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Polymerase Chain Reaction (PCR) Test Market Size (2018-2029)
10.2 Middle East & Africa Polymerase Chain Reaction (PCR) Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Polymerase Chain Reaction (PCR) Test Market Size by Country (2018-2023)
10.4 Middle East & Africa Polymerase Chain Reaction (PCR) Test Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Polymerase Chain Reaction (PCR) Test Introduction
11.1.4 Abbott Laboratories Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies Inc.
11.2.1 Agilent Technologies Inc. Company Detail
11.2.2 Agilent Technologies Inc. Business Overview
11.2.3 Agilent Technologies Inc. Polymerase Chain Reaction (PCR) Test Introduction
11.2.4 Agilent Technologies Inc. Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.2.5 Agilent Technologies Inc. Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Polymerase Chain Reaction (PCR) Test Introduction
11.3.4 Abbott Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.3.5 Abbott Recent Development
11.4 Asuragen, Inc.
11.4.1 Asuragen, Inc. Company Detail
11.4.2 Asuragen, Inc. Business Overview
11.4.3 Asuragen, Inc. Polymerase Chain Reaction (PCR) Test Introduction
11.4.4 Asuragen, Inc. Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.4.5 Asuragen, Inc. Recent Development
11.5 Danaher
11.5.1 Danaher Company Detail
11.5.2 Danaher Business Overview
11.5.3 Danaher Polymerase Chain Reaction (PCR) Test Introduction
11.5.4 Danaher Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.5.5 Danaher Recent Development
11.6 Biocartis Group Nv
11.6.1 Biocartis Group Nv Company Detail
11.6.2 Biocartis Group Nv Business Overview
11.6.3 Biocartis Group Nv Polymerase Chain Reaction (PCR) Test Introduction
11.6.4 Biocartis Group Nv Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.6.5 Biocartis Group Nv Recent Development
11.7 µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ
11.7.1 µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ Company Detail
11.7.2 µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ Business Overview
11.7.3 µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ Polymerase Chain Reaction (PCR) Test Introduction
11.7.4 µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.7.5 µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ Recent Development
11.8 Bio-Rad Laboratories, Inc.
11.8.1 Bio-Rad Laboratories, Inc. Company Detail
11.8.2 Bio-Rad Laboratories, Inc. Business Overview
11.8.3 Bio-Rad Laboratories, Inc. Polymerase Chain Reaction (PCR) Test Introduction
11.8.4 Bio-Rad Laboratories, Inc. Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.8.5 Bio-Rad Laboratories, Inc. Recent Development
11.9 Genmark Diagnostics, Inc.
11.9.1 Genmark Diagnostics, Inc. Company Detail
11.9.2 Genmark Diagnostics, Inc. Business Overview
11.9.3 Genmark Diagnostics, Inc. Polymerase Chain Reaction (PCR) Test Introduction
11.9.4 Genmark Diagnostics, Inc. Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.9.5 Genmark Diagnostics, Inc. Recent Development
11.10 Hologic, Inc.
11.10.1 Hologic, Inc. Company Detail
11.10.2 Hologic, Inc. Business Overview
11.10.3 Hologic, Inc. Polymerase Chain Reaction (PCR) Test Introduction
11.10.4 Hologic, Inc. Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.10.5 Hologic, Inc. Recent Development
11.11 Luminex Corporation
11.11.1 Luminex Corporation Company Detail
11.11.2 Luminex Corporation Business Overview
11.11.3 Luminex Corporation Polymerase Chain Reaction (PCR) Test Introduction
11.11.4 Luminex Corporation Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.11.5 Luminex Corporation Recent Development
11.12 Meridian Bioscience, Inc.
11.12.1 Meridian Bioscience, Inc. Company Detail
11.12.2 Meridian Bioscience, Inc. Business Overview
11.12.3 Meridian Bioscience, Inc. Polymerase Chain Reaction (PCR) Test Introduction
11.12.4 Meridian Bioscience, Inc. Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.12.5 Meridian Bioscience, Inc. Recent Development
11.13 Qiagen N.V.
11.13.1 Qiagen N.V. Company Detail
11.13.2 Qiagen N.V. Business Overview
11.13.3 Qiagen N.V. Polymerase Chain Reaction (PCR) Test Introduction
11.13.4 Qiagen N.V. Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.13.5 Qiagen N.V. Recent Development
11.14 Quantumdx Group
11.14.1 Quantumdx Group Company Detail
11.14.2 Quantumdx Group Business Overview
11.14.3 Quantumdx Group Polymerase Chain Reaction (PCR) Test Introduction
11.14.4 Quantumdx Group Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.14.5 Quantumdx Group Recent Development
11.15 Quidel, Inc.
11.15.1 Quidel, Inc. Company Detail
11.15.2 Quidel, Inc. Business Overview
11.15.3 Quidel, Inc. Polymerase Chain Reaction (PCR) Test Introduction
11.15.4 Quidel, Inc. Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.15.5 Quidel, Inc. Recent Development
11.16 Roche
11.16.1 Roche Company Detail
11.16.2 Roche Business Overview
11.16.3 Roche Polymerase Chain Reaction (PCR) Test Introduction
11.16.4 Roche Revenue in Polymerase Chain Reaction (PCR) Test Business (2018-2023)
11.16.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
Agilent Technologies Inc.
Abbott
Asuragen, Inc.
Danaher
Biocartis Group Nv
µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ
Bio-Rad Laboratories, Inc.
Genmark Diagnostics, Inc.
Hologic, Inc.
Luminex Corporation
Meridian Bioscience, Inc.
Qiagen N.V.
Quantumdx Group
Quidel, Inc.
Roche
Ìý
Ìý
*If Applicable.